Re:‘Pharmacy of the developing world’ under attack from the ...
by brianwawok on Tuesday August 25, 2015 @10:34AM
(#10116749)
Government funding the research + selling the drugs at cost would benefit mankind overall... but then politicians would decide how many $ to spend researching which drug per year, which has it's own downsides..
Re:‘Pharmacy of the developing world’ under attack from the ...
by ekianjo on Tuesday August 25, 2015 @10:44AM
(#10116845)
> Government funding the research + selling the drugs at cost would benefit mankind overall...
Wasnt that how NASA was supposed to work ? Oh wait, we know how it went...
Re:‘Pharmacy of the developing world’ under attack from the ...
by RodericDay on Tuesday August 25, 2015 @11:11AM
(#10117033)
We went to the moon?
Re:‘Pharmacy of the developing world’ under attack from the ...
by ekianjo on Tuesday August 25, 2015 @11:17AM
(#10117083)
I'm talking about what happened to NASA after that. Obviously look at the ridiculous budgets they have now.
Re:‘Pharmacy of the developing world’ under attack from the ...
by JustSomeNobody on Tuesday August 25, 2015 @10:47AM
(#10116862)
The problem, yet again, is quarterly earnings reports.
It takes sometimes billions to find the next new drug. In order to keep showing quarter after quarter of sustained growth that investors demand, they have to continue raising prices.
Fixing patents, wouldn't necessarily fix this problem.
Re:‘Pharmacy of the developing world’ under attack from the ...
by ekianjo on Tuesday August 25, 2015 @10:48AM
(#10116877)
> It takes sometimes billions to find the next new drug. In order to keep showing quarter after quarter of sustained growth that investors demand, they have to continue raising prices.
you don't raise prices on drugs that easily, Prices changes are heavily regulated as well.
Re:‘Pharmacy of the developing world’ under attack from the ...
by judemelancon on Tuesday August 25, 2015 @05:05PM
(#10119443)
I am aware of no such regulation in the USA. Are you?
It's (arguably) not the market here that's the problem, but the patent. The patent means that generic manufacturers can't get in on the market and create a commodity out of it with a race to the bottom on price. The problem isn't the market, but the absolute lack of a market created by the exclusivity of a patent.
We need to find a way as a society that these companies can profit off the research and development of these drugs while still allowing generic manufacturers to do what they do best: create a real, competitive market to produce the drug in bulk.
Unfortunately I don't think there's any clear answers here.